XML 67 R56.htm IDEA: XBRL DOCUMENT
v3.19.2

Related Parties Transactions (Details Textual) - USD ($) |  |  |  |  |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
May 27, 2019 | May 12, 2019 | Feb. 02, 2019 | Aug. 25, 2018 | Jun. 27, 2018 | Apr. 12, 2017 | May 06, 2016 | Jan. 20, 2019 | Jan. 18, 2018 | Sep. 30, 2017 | Jul. 24, 2017 | Jun. 30, 2019 | Jun. 30, 2018 | Jun. 30, 2019 | Jun. 30, 2018 | Dec. 31, 2018 | Jan. 26, 2017
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expenses |  |  |  |  |  |  |  |  |  |  |  | $ 132,686 | $ 116,802 | $ 262,572 | $ 223,656 |  |
Common stock new issues |  |  |  |  |  |  |  |  |  |  |  |  |  | 694,219 | 80,000 |  |
Due from related parties |  |  |  |  |  |  |  |  |  |  |  | 180,736 |  | 180,736 |  | $ 59,477 |
Collaborative Arrangement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock new issues |  |  |  |  |  |  | $ 900,000 |  |  |  | $ 3,000,000 |  |  | $ 3,000,000 |  |  |
Common stock new issues, shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 428,571 |  |  |
Rgene Corporation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate working capital |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 25,025 |  | $ 19,477 |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  | 0.00% |
Due from related parties |  |  |  |  |  |  |  |  |  |  |  | 25,025 |  | $ 25,025 |  | $ 19,477 |
Loan Agreement One [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan maturity date | Dec. 31, 2019 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan agreement, description | On May 27, 2019, BioLite Taiwan entered into a loan agreement with AsiaGene for NT$100,000, equivalent to $3,225 to meet its working capital needs, pursuant to which the interest bears at 12% per annum. This loan is matured on December 31, 2019. As of June 30, 2019, the accrued interest was $31. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accrued interest | $ 31 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate working capital | $ 3,225 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate percentage | 12.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan Agreement One [Member] | NT [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate working capital | $ 100,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
BioFirst (Australia) Pty Ltd. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate working capital |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 40,000 |  | $ 40,000 |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  | 0.00% |
Due from related parties |  |  |  |  |  |  |  |  |  |  |  | 40,000 |  | $ 40,000 |  | $ 40,000 |
BioHopeKing Corporation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Due from related parties |  |  |  |  |  |  |  |  |  |  |  | 111,780 |  | 111,780 |  |  |
LBG USA, Inc.[Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate working capital |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 675 |  | $ 0 |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  | 0.00% |
Due from related parties |  |  |  |  |  |  |  |  |  |  |  | 675 |  | $ 675 |  |  |
BioLite Taiwan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan maturity date |  |  |  |  |  |  |  |  |  |  |  |  |  | Apr. 14, 2020 |  |  |
Outstanding loan |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 94,990 |  | 65,495 |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,719 |  | 0 |
Interest expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,874 | 0 |  |
Aggregate working capital |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 94,990 |  |  |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 12.00% |  |  |
BioLite Taiwan [Member] | NT [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan maturity date |  |  |  |  |  |  |  |  |  |  |  |  |  | Apr. 14, 2020 |  |  |
Aggregate working capital |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,950,000 |  |  |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 12.00% |  |  |
LionGene Corporation (the "LionGene") [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate working capital |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 428,099 |  | $ 458,348 |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  | 0.00% |
BriVision and BioFirst Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total commitment |  |  | $ 693,000 |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 950,000
Loan maturity date |  |  | Feb. 01, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding loan |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 233,000 |  | $ 692,980 |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 18,942 |  | 281 |
Interest expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 18,681 | 56,837 |  |
Interest rate percentage |  |  | 12.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |
BioLite Taiwan and BioFirst Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan maturity date |  |  |  |  |  |  |  |  |  |  |  |  |  | May 27, 2020 |  |  |
Outstanding loan |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 625,646 |  | 663,810 |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 168,370 |  | 127,976 |
Interest expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | 40,338 | 54,887 |  |
Aggregate working capital |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 625,646 |  |  |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 12.00% |  |  |
BioLite Taiwan and BioFirst Agreement [Member] | NT [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate working capital |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 19,430,000 |  |  |
BioFirst [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |
Outstanding advance |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 709,444 |  |  |
BioLite BVI and BioFirst Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan maturity date |  | May 11, 2020 |  |  |  | May 11, 2019 |  |  |  |  |  |  |  |  |  |  |
Loan agreement, description |  |  |  |  |  | On April 12, 2017, BioLite BVI and BioFirst entered into a loan agreement for NT$30,000,000, equivalent to $987,134 to meet its working capital needs. Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum). BioLite BVI and BioFirst extended the loan with the same interest rate and amount for one year. |  |  |  |  |  |  |  |  |  |  |
Outstanding loan |  |  |  |  |  |  |  |  |  |  |  |  |  | 987,134 |  | 981,000 |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 279,317 |  | 222,000 |
Interest expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | 57,317 | 60,113 |  |
Aggregate working capital |  |  |  |  |  | $ 987,134 |  |  |  |  |  |  |  |  |  |  |
BioLite BVI and BioFirst Agreement [Member] | NT [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate working capital |  |  |  |  |  | $ 30,000,000 |  |  |  |  |  |  |  |  |  |  |
Asiagene Corporation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding loan |  |  |  |  |  |  |  |  |  |  |  |  |  | 160,000 |  | 160,000 |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 22,387 |  | 12,866 |
Interest expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | 9,521 | 8,732 |  |
Interest rate percentage |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |  |  |
Related party transactions, description |  |  |  |  |  |  |  |  |  | Pursuant to the Investment and Equity Transfer Agreement, Everfront agreed to purchase 2,000,000 common shares of the Company owned by AsiaGene at $1.60 per share in a total amount of $3,200,000, of which $160,000 is due before September 15, 2017 and the remaining amount of $3,040,000 is due before December 15, 2017. AsiaGene also agreed to loan the proceeds to the Company for working capital purpose. |  |  |  |  |  |  |
Due from related parties |  |  |  |  |  |  |  |  |  |  |  | $ 3,256 |  | 3,256 |  |  |
Yuangene Corporation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan maturity date |  |  |  |  |  |  |  | Jan. 19, 2020 | Jan. 19, 2019 |  |  |  |  |  |  |  |
Loan agreement, description |  |  |  |  |  |  |  |  | Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the Company is required to pay interest monthly to the lender. |  |  |  |  |  |  |  |
Outstanding loan |  |  |  |  |  |  |  |  |  |  |  |  |  | 50,000 |  | 50,000 |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 8,696 |  | 5,721 |
Interest expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,975 | 2,696 |  |
Aggregate working capital |  |  |  |  |  |  |  |  | $ 50,000 |  |  |  |  | $ 42,690 |  | $ 42,690 |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |
Keypoint Technology Ltd [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 10,000 | 0 |  |
Interest rate percentage |  |  |  |  | 8.00% |  |  |  |  |  |  |  |  |  |  |  |
Related party transactions, description |  |  |  |  | On June 27, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the “Keypoint Note”) in an aggregate principal amount of $250,000 to Keypoint Technology Ltd. (“Keypoint”) (See Note 8). |  |  |  |  |  |  |  |  |  |  |  |
Aggregate principal amount |  |  |  |  | $ 250,000 |  |  |  |  |  |  |  |  |  |  |  |
The Jiangs [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |
Outstanding advance |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 381,375 |  |  |
Mr. Tsung-Shann Jiang, Ms. Shu-Ling Jiang and Ms. Mei-Ling Jiang [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 22,014 |  |  |
Interest rate percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 12.00% |  |  |
Outstanding advance |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 795,340 |  |  |
Yoshinobu Odaira [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Related Parties Transactions (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 10,000 | $ 0 |  |
Interest rate percentage |  |  |  | 8.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Related party transactions, description |  |  |  | The Company issued an eighteen-month term unsecured convertible promissory note (the “Odaira Note”) in an aggregate principal amount of $250,000 to Yoshinobu Odaira (“Odaira”) |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate principal amount |  |  |  | $ 250,000 |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Aggregate working capital. + References No definition available. + Details
Name: | abvcd_AggregateWorkingcapital
Namespace Prefix: | abvcd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | abvcd_RelatedPartiesTransactionsTextualAbstract
Namespace Prefix: | abvcd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | abvcd_StockIssuedValue
Namespace Prefix: | abvcd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Face (par) amount of debt instrument at time of issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400 + Details
Name: | us-gaap_DebtInstrumentFaceAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Increase for accrued, but unpaid interest on the debt instrument for the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(f)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_DebtInstrumentIncreaseAccruedInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_DebtInstrumentInterestRateTerms
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(2)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_DebtInstrumentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(k)(1)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(11)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)(a)(2)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 + Details
Name: | us-gaap_DueFromRelatedPartiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_IncreaseDecreaseInPrepaidExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of the cost of borrowed funds accounted for as interest expense. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (210.5-03(11)) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260 + Details
Name: | us-gaap_InterestExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. + References No definition available. + Details
Name: | us-gaap_OtherCommitment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(k)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 30 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=119202524&loc=SL77919370-209981 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=77911099&loc=d3e36975-112693 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918703-209980 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=77888430&loc=SL77919784-209982 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(23)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_RelatedPartyTransactionDescriptionOfTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties. + References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition For the form of debt having an initial term of less than one year or less than the normal operating cycle, if longer, average borrowings during the period. + References No definition available. + Details
Name: | us-gaap_ShorttermDebtAverageOutstandingAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_RgeneCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_LoanAgreementOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | abvcd_TypeOfCurrencyAxis=abvcd_NTMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_BioFirstAustraliaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_BioHopeKingCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_LbgUsaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_BioLiteTaiwanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_LionGeneCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_BriVisionAndBioFirstAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_BioLiteTaiwanAndBioFirstAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_BioFirstCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_BioLiteBVIAndBioFirstLoanAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_AsiageneCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_YuangeneCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_KeypointTechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_TheJiangsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_MrTsungShannJiangMsShuLingJiangAndMsMeiLingJiangMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_YoshinobuOdairaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |